RE: CHK113 Feb 2018 16:53
Yes, it's an important update because it's more validation for SAR but a re-rate? Also, I believe the milestones are fixed. So we get 80mil and that's it, irrespective of how many concurrent trails SRRA run. I do agree with the below that CHK1 was licenced on cheap but 2/3 percent of billions in royalties would make up for it.
My loose analogy is when Apple bring out a new IPhone do Samsung, who supply a lot of the chips get a market boost? Other than an increase in chips sales, they don't. Nor do they thank them for supplying the chips.
I would love a nice rerate, just don't think this will generate one. Unless a milestone is triggered or the trial has shown some efficacy that can't be ignored.